Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A

Published:2016-11 Issue:2 Volume:480 Page:248-253
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Lin Ping-ping,Li Xue-ning,Yuan Fei,Chen Wei-li,Yang Meng-jie,Xu Hong-rong

Funder

Shanghai Committee of Science and Technology

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?;Francis;Trends Pharmacol. Sci.,2005

2. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine;Wang;Acta Pharmacol. Sin.,2006

3. The role of phytochemicals in the treatment and prevention of dementia;Howes;Drugs & Aging,2011

4. Huperzine A: is it an effective disease-modifying drug for Alzheimer's disease?;Qian;Front. Aging Neurosci.,2014

5. Pharmacokinetics of huperzine A following oral administration to human volunteers;Li;Eur. J. Drug Metabolism Pharmacokinet.,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease;Biotechnology Advances;2022-11

2. Genome sequencing of Colletotrichum gloeosporioides ES026 reveals plausible pathway of HupA;Molecular Biology Reports;2022-09-26

3. UHPLC-HRMS study of pharmacokinetics of a novel hybrid cholinesterase inhibitor K1234: A comparison between in silico, in vitro and in vivo data;Journal of Pharmaceutical and Biomedical Analysis;2022-09

4. An Acetylcholinesterase Sensor Based on a Pillar[6]arene–Silver Nanoparticle Composite for the Determination of Drugs for the Treatment of Alzheimer’s Disease;Journal of Analytical Chemistry;2022-04

5. Pharmacogenetics in Alzheimer’s Disease Drug Discovery and Personalized Treatment;Alzheimer's Disease Drug Development;2022-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3